Skip to main navigation Skip to search Skip to main content

Study to Compare the Effect of 24 Weeks Treatment with LAF237 to Placebo as Add-On Therapy to Pioglitazone in Patients with Type 2 Diabetes Inadequately Controlled with Thiazolidinedione Monotherapy

Project: Research

Project Details

StatusFinished
Effective start/end date04/6/04 → 08/1/06

Funding

  • Novartis Pharmaceuticals Corporation: $2.00